Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar) (FAST)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Loraine Busetto, Dr.
- Phone Number: 34149 +49622156
- Email: loraine.busetto@med.uni-heidelberg.de
Study Contact Backup
- Name: Maja Zenz, PhD
- Phone Number: 34391 +49622156
- Email: maja.zenz@med.uni-heidelberg.de
Study Locations
-
-
-
Heidelberg, Germany, 69120
- Recruiting
- Heidelberg University Hospital
-
Contact:
- Loraine Busetto, Dr.
- Phone Number: 34149 +49622156
- Email: loraine.busetto@med.uni-heidelberg.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years or older
- Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST)
- informed consent
Exclusion Criteria:
- no informed consent
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Primary CSC (Comprehensive Stroke center) admission
Patients with primary admission to endovascular-ready hospital (comprehensive stroke center)
|
Observational study without study related intervention
|
|
Primary non-CSC (non-Comprehensive Stroke Center) SU (Stroke Unit) admission
Patients with primary admission to non-endovascular-ready hospital with (regional/local) stroke unit
|
Observational study without study related intervention
|
|
Non-acute stroke hospital admission
Patients with primary admission to non-acute stroke-ready hospital
|
Observational study without study related intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional outcome
Time Frame: 3 months after intervention
|
Functional outcome according to the modified Rankin Scale (mRS)
|
3 months after intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients receiving acute recanalisation therapies of all referrals
Time Frame: 24 h after stroke onset
|
Number of patients receiving thrombolysis and/or thrombectomy of all patients included in to the Network via the database.
|
24 h after stroke onset
|
|
Referral rates
Time Frame: Stroke onset to discharge from acute hospital; through study completion, an average of 2 years
|
Referral rates by stroke service level (i.e.
type of treatment center)
|
Stroke onset to discharge from acute hospital; through study completion, an average of 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Wolfgang Wick, Prof. Dr., University Hospital Heidelberg
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FAST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.